Cargando…
Is the United States Still Dominant in the Global Pharmaceutical Innovation Network?
The dramatic growth of research and development activities in the pharmaceutical sector in emerging economies raises the question of whether the United States still keeps its dominant role in the global pharmaceutical innovation landscape. This paper focuses on investigating the role of the United S...
Autores principales: | Hu, Yuanjia, Scherngell, Thomas, Man, Si Nga, Wang, Yitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818371/ https://www.ncbi.nlm.nih.gov/pubmed/24223710 http://dx.doi.org/10.1371/journal.pone.0077247 |
Ejemplares similares
-
Obstacles and opportunities in Chinese pharmaceutical innovation
por: Ni, Jingyun, et al.
Publicado: (2017) -
Global landscape of patents related to human coronaviruses
por: Liu, Kunmeng, et al.
Publicado: (2021) -
The dynamics of global R&D collaboration networks in ICT: Does China catch up with the US?
por: Scherngell, Thomas, et al.
Publicado: (2020) -
The geographical dynamics of global R&D collaboration networks in robotics: Evidence from co-patenting activities across urban areas worldwide
por: Scherngell, Thomas, et al.
Publicado: (2023) -
An investigation Into Traditional Chinese Medicine Hospitals in China: Development Trend and Medical Service Innovation
por: Wang, Liang, et al.
Publicado: (2016)